YZYBIO-B (02496) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile IPO ›

Industry

Innovative Drugs & Biologics 1.38%

124 stocks in this industry

7 >7%

6 5~7%

18 3~5%

47 0~3%

10 0%

25 0~3%

6 3~5%

2 5~7%

3 >7%

Down 78 Up 36

Industry RankingsValue (HKD)Rank

Revenue (Last FY)78.39M93/112

Net Profit (Last FY)-99.35M65/125

Change is the 2026-10-12 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

Zhou Pengfei Executive Director

Wen Zhicheng Executive Director

Yuan Qian Non-Executive Director

Zhou Hongfeng Non-Executive Director

Pang Zhenhai Non-Executive Director

Hui Xiwu Non-Executive Director

Xie Shouwu Non-Executive Director

Cheng Bin Independent Non-Executive Director

Fu Lili Independent Non-Executive Director

Deng Yuezhen Independent Non-Executive Director

Chen Bin Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-06-25.

About this page

This page shows YZYBIO-B (02496) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

YZYBIO-B 02496

Company Information

Industry

Management

YZYBIO-B 02496·

Company Information

Industry

Management

YZYBIO-B 02496